PolyPid Historical Financial Ratios
| PYPD Stock | USD 3.55 0.12 3.50% |
PolyPid is promptly reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 0.0, Stock Based Compensation To Revenue of 0.0, Capex To Depreciation of 0.1 or Ev To Sales of 0.0 will help investors to properly organize and evaluate PolyPid financial condition quickly.
PolyPid |
About PolyPid Financial Ratios Analysis
PolyPidFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate PolyPid investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on PolyPid financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across PolyPid history.
PolyPid Financial Ratios Chart
Add Fundamental
Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most ratios from PolyPid's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 2.48, whereas Book Value Per Share is forecasted to decline to (1.57).
PolyPid fundamentals Correlations
Click cells to compare fundamentals
PolyPid Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PolyPid fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 8.17 | 1.3 | 2.97 | 2.31 | (2.55) | (2.67) | |
| Book Value Per Share | 69.8 | 227.85 | 58.06 | 9.05 | (1.49) | (1.57) | |
| Free Cash Flow Yield | (0.0722) | (0.24) | (0.33) | (2.66) | (3.27) | (3.1) | |
| Operating Cash Flow Per Share | (39.16) | (67.61) | (51.9) | (52.99) | (12.27) | (12.89) | |
| Capex To Depreciation | 0.93 | 1.16 | 2.68 | 1.03 | 0.11 | 0.1 | |
| Pb Ratio | 8.17 | 1.3 | 2.97 | 2.31 | (2.55) | (2.67) | |
| Free Cash Flow Per Share | (41.15) | (71.29) | (56.69) | (55.72) | (12.41) | (13.03) | |
| Roic | 0.41 | (0.35) | (1.14) | (2.12) | (2.77) | (2.63) | |
| Inventory Turnover | 2.7 | 1.57 | (0.0497) | 8.08 | 7.27 | 7.64 | |
| Net Income Per Share | 10.72 | (110.59) | (65.24) | (61.04) | (16.99) | (17.84) | |
| Days Of Inventory On Hand | 135.29 | 232.99 | (7.3K) | 45.17 | 51.95 | 54.55 | |
| Payables Turnover | 0.6 | 1.04 | 0.27 | 1.51 | 2.36 | 2.48 | |
| Cash Per Share | 60.07 | 139.24 | 51.6 | 19.45 | 3.99 | 3.79 | |
| Pocfratio | (14.55) | (4.39) | (3.32) | (0.4) | (0.31) | (0.33) | |
| Interest Coverage | (437.24) | (1.2K) | (1.5K) | (38.01) | (13.36) | (14.03) | |
| Capex To Operating Cash Flow | (0.0506) | (0.0545) | (0.0924) | (0.0515) | (0.0114) | (0.0119) | |
| Pfcf Ratio | (13.85) | (4.17) | (3.04) | (0.38) | (0.31) | (0.32) | |
| Days Payables Outstanding | 609.36 | 351.29 | 1.4K | 241.99 | 154.65 | 146.92 | |
| Income Quality | 2.51 | 0.59 | 0.76 | 0.87 | 0.72 | 0.44 | |
| Roe | 0.15 | (0.49) | (1.12) | (6.74) | 11.39 | 11.96 | |
| Ev To Operating Cash Flow | (14.33) | (4.19) | (3.01) | (0.55) | (0.67) | (0.7) | |
| Pe Ratio | 53.19 | (2.69) | (2.64) | (0.34) | (0.22) | (0.23) | |
| Return On Tangible Assets | 0.14 | (0.47) | (0.92) | (1.52) | (1.55) | (1.63) | |
| Ev To Free Cash Flow | (13.64) | (3.98) | (2.76) | (0.52) | (0.66) | (0.69) | |
| Earnings Yield | 0.0188 | (0.37) | (0.38) | (2.91) | (4.47) | (4.25) | |
| Net Debt To E B I T D A | 0.66 | 0.12 | 0.24 | (0.14) | (0.3) | (0.29) | |
| Current Ratio | 10.63 | 16.54 | 4.46 | 1.64 | 0.83 | 0.79 | |
| Tangible Book Value Per Share | 69.8 | 227.85 | 58.06 | 9.05 | (1.49) | (1.57) | |
| Graham Number | 129.73 | 752.96 | 291.93 | 111.49 | 23.89 | 22.69 | |
| Shareholders Equity Per Share | 69.8 | 227.85 | 58.06 | 9.05 | (1.49) | (1.57) | |
| Capex Per Share | 1.98 | 3.68 | 4.8 | 2.73 | 0.14 | 0.13 | |
| Graham Net Net | 54.11 | 130.05 | 20.75 | (11.69) | (8.44) | (8.87) | |
| Interest Debt Per Share | 0.0948 | 0.0338 | 0.0532 | 20.97 | 8.61 | 8.18 | |
| Enterprise Value Over E B I T D A | (41.85) | (2.53) | (2.35) | (0.52) | (0.57) | (0.6) | |
| Price Earnings Ratio | 53.19 | (2.69) | (2.64) | (0.34) | (0.22) | (0.23) | |
| Price Book Value Ratio | 8.17 | 1.3 | 2.97 | 2.31 | (2.55) | (2.67) | |
| Price Earnings To Growth Ratio | (2.7) | 0.002373 | 0.0644 | 0.0533 | 0.003099 | 0.003254 | |
| Days Of Payables Outstanding | 609.36 | 351.29 | 1.4K | 241.99 | 154.65 | 146.92 | |
| Price To Operating Cash Flows Ratio | (14.55) | (4.39) | (3.32) | (0.4) | (0.31) | (0.33) | |
| Price To Free Cash Flows Ratio | (13.85) | (4.17) | (3.04) | (0.38) | (0.31) | (0.32) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.22) | Return On Assets (0.65) | Return On Equity (4.97) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.